+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gastrointestinal Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030

  • ID: 5292709
  • Report
  • February 2021
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Takeda Pharmaceticals
  • MORE
Gastrointestinal Drugs Global Market Report 2021: COVID-19 Implications and Growth to 2030 covers this critical market and the impact on it from the COVID-19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for gastrointestinal drugs. Vitamins and Minerals play a crucial role in the treatment of pateints with COVID-19 as they are used as immunity boosters.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the gastrointestinal drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Gastrointestinal Drugs Market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider gastrointestinal drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The gastrointestinal drugs market section of the report gives context. It compares the gastrointestinal drugs market with other segments of the gastrointestinal drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, gastrointestinal drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Antacids; Antiulcerants; Vitamin and Minerals; Antiobesity; Antiemetics and Antinauseants; Antidiarrhoeals
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, gastrointestinal drugs indicators comparison.

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Takeda Pharmaceticals
  • MORE
1. Executive Summary

2. Report Structure

3. Gastrointestinal Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Gastrointestinal Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Gastrointestinal Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Gastrointestinal Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Gastrointestinal Drugs Market Trends and Strategies

8. Impact of COVID-19 on Gastrointestinal Drugs

9. Gastrointestinal Drugs Market Size and Growth
9.1. Market Size
9.2. Historic Market Growth, Value ($ Billion)
9.2.1. Drivers of the Market
9.2.2. Restraints on the Market
9.3. Forecast Market Growth, Value ($ Billion)
9.3.1. Drivers of the Market
9.3.2. Restraints on the Market

10. Gastrointestinal Drugs Market Regional Analysis
10.1. Global Gastrointestinal Drugs Market, 2020, by Region, Value ($ Billion)
10.2. Global Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
10.3. Global Gastrointestinal Drugs Market, Growth and Market Share Comparison, by Region

11. Gastrointestinal Drugs Market Segmentation
11.1. Global Gastrointestinal Drugs Market, Segmentation by Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Antacids
  • Antiulcerants
  • Vitamin and Minerals
  • Antiobesity
  • Antiemetics and Antinauseants
  • Antidiarrhoeals
11.2. Global Gastrointestinal Drugs Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
11.3. Global Gastrointestinal Drugs Market, Segmentation by Route of Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
11.4. Global Gastrointestinal Drugs Market, Segmentation by Drug Classification, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
11.5. Global Gastrointestinal Drugs Market, Segmentation by Mode of Purchase, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
12. Gastrointestinal Drugs Market Metrics
12.1. Gastrointestinal Drugs Market Size, Percentage of GDP, 2015-2025, Global
12.2. Per Capita Average Gastrointestinal Drugs Market Expenditure, 2015-2025, Global

13. Asia-Pacific Gastrointestinal Drugs Market
13.1. Asia-Pacific Gastrointestinal Drugs Market Overview
  • Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
13.2. Asia-Pacific, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
13.3. Asia-Pacific, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
13.4. Asia-Pacific, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
13.5. Asia-Pacific, Gastrointestinal Drugs Market Metrics
13.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, Asia-Pacific Countries
13.6. Asia-Pacific Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7. Asia-Pacific Gastrointestinal Drugs Market: Country Analysis
13.7.1. China Gastrointestinal Drugs Market
13.7.1.1. China Gastrointestinal Drugs Market Overview
13.7.1.2. China Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.1.3. China Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2. Australia Gastrointestinal Drugs Market
13.7.2.1. Australia Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.2.2. Australia Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.3. Hong Kong Gastrointestinal Drugs Market
13.7.3.1. Hong Kong Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4. India Gastrointestinal Drugs Market
13.7.4.1. India Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.4.2. India Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5. Indonesia Gastrointestinal Drugs Market
13.7.5.1. Indonesia Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.5.2. Indonesia Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6. Japan Gastrointestinal Drugs Market
13.7.6.1. Japan Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.6.2. Japan Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.7. Malaysia Gastrointestinal Drugs Market
13.7.7.1. Malaysia Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.8. New Zealand Gastrointestinal Drugs Market
13.7.8.1. New Zealand Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.9. Philippines Gastrointestinal Drugs Market
13.7.9.1. Philippines Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.10. Singapore Gastrointestinal Drugs Market
13.7.10.1. Singapore Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11. South Korea Gastrointestinal Drugs Market
13.7.11.1. South Korea Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.11.2. South Korea Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.12. Thailand Gastrointestinal Drugs Market
13.7.12.1. Thailand Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
13.7.13. Vietnam Gastrointestinal Drugs Market
13.7.13.1. Vietnam Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

14. Western Europe Gastrointestinal Drugs Market
14.1. Western Europe Gastrointestinal Drugs Market Overview
14.2. Western Europe, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
14.3. Western Europe, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
14.4. Western Europe, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
14.5. Western Europe, Gastrointestinal Drugs Market Metrics
14.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, Western Europe Countries
14.6. Western Europe Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7. Western Europe Gastrointestinal Drugs Market: Country Analysis
14.7.1. Austria Gastrointestinal Drugs Market
14.7.1.1. Austria Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.2. Belgium Gastrointestinal Drugs Market
14.7.2.1. Belgium Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.3. Denmark Gastrointestinal Drugs Market
14.7.3.1. Denmark Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.4. Finland Gastrointestinal Drugs Market
14.7.4.1. Finland Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5. France Gastrointestinal Drugs Market
14.7.5.1. France Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.5.2. France Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6. Germany Gastrointestinal Drugs Market
14.7.6.1. Germany Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.6.2. Germany Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.7. Ireland Gastrointestinal Drugs Market
14.7.7.1. Ireland Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.8. Italy Gastrointestinal Drugs Market
14.7.8.1. Italy Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.9. Netherlands Gastrointestinal Drugs Market
14.7.9.1. Netherlands Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.10. Norway Gastrointestinal Drugs Market
14.7.10.1. Norway Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.11. Portugal Gastrointestinal Drugs Market
14.7.11.1. Portugal Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.12. Spain Gastrointestinal Drugs Market
14.7.12.1. Spain Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.13. Sweden Gastrointestinal Drugs Market
14.7.13.1. Sweden Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.14. Switzerland Gastrointestinal Drugs Market
14.7.14.1. Switzerland Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15. UK Gastrointestinal Drugs Market
14.7.15.1. UK Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
14.7.15.2. UK Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

15. Eastern Europe Gastrointestinal Drugs Market
15.1. Eastern Europe Gastrointestinal Drugs Market Overview
15.2. Eastern Europe, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
15.3. Eastern Europe, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
15.4. Eastern Europe, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
15.5. Eastern Europe, Gastrointestinal Drugs Market Metrics
15.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, Eastern Europe Countries
15.6. Eastern Europe Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7. Eastern Europe Gastrointestinal Drugs Market: Country Analysis
15.7.1. Czech Republic Gastrointestinal Drugs Market,
15.7.1.1. Czech Republic Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.2. Poland Gastrointestinal Drugs Market
15.7.2.1. Poland Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.3. Romania Gastrointestinal Drugs Market
15.7.3.1. Romania Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4. Russia Gastrointestinal Drugs Market
15.7.4.1. Russia Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
15.7.4.2. Russia Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

16. North America Gastrointestinal Drugs Market
16.1. North America Gastrointestinal Drugs Market Overview
16.2. North America, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
16.3. North America, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
16.4. North America, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
16.5. North America, Gastrointestinal Drugs Market Metrics
16.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, North America Countries
16.6. North America Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7. North America Gastrointestinal Drugs Market: Country Analysis
16.7.1. Canada Gastrointestinal Drugs Market
16.7.1.1. Canada Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.2. Mexico Gastrointestinal Drugs Market
16.7.2.1. Mexico Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3. USA Gastrointestinal Drugs Market
16.7.3.1. USA Gastrointestinal Drugs Market Overview
16.7.3.2. USA Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
16.7.3.3. USA Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

17. South America Gastrointestinal Drugs Market
17.1. South America Gastrointestinal Drugs Market Overview
17.2. South America, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
17.3. South America, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
17.4. South America, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
17.5. South America, Gastrointestinal Drugs Market Metrics
17.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, South America Countries
17.6. South America Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7. South America Gastrointestinal Drugs Market: Country Analysis
17.7.1. Argentina Gastrointestinal Drugs Market
17.7.1.1. Argentina Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2. Brazil Gastrointestinal Drugs Market
17.7.1.1. Brazil Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.2.2. Brazil Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.3. Chile Gastrointestinal Drugs Market
17.7.3.1. Chile Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.4. Colombia Gastrointestinal Drugs Market
17.7.4.1. Colombia Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.5. Peru Gastrointestinal Drugs Market
17.7.5.1. Peru Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
17.7.6. Venezuela Gastrointestinal Drugs Market
17.7.6.1. Venezuela Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

18. Middle East Gastrointestinal Drugs Market
18.1. Middle East Gastrointestinal Drugs Market Overview
18.2. Middle East, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
18.3. Middle East, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
18.4. Middle East, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
18.5. Middle East, Gastrointestinal Drugs Market Metrics
18.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, Middle East Countries
18.6. Middle East Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7. Middle East Gastrointestinal Drugs Market: Country Analysis
18.7.1. Saudi Arabia Gastrointestinal Drugs Market
18.7.1.1. Saudi Arabia Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.2. Israel Gastrointestinal Drugs Market
18.7.2.1. Israel Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.3. Turkey Gastrointestinal Drugs Market
18.7.3.1. Turkey Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
18.7.4. UAE Gastrointestinal Drugs Market
18.7.4.1. UAE Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

19. Africa Gastrointestinal Drugs Market
19.1. Africa Gastrointestinal Drugs Market Overview
19.2. Africa, Gastrointestinal Drugs Market, 2020, by Country, Value ($ Billion)
19.3. Africa, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Country
19.4. Africa, Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Growth and Market Share Comparison, by Country
19.5. Africa, Gastrointestinal Drugs Market Metrics
19.5.1. Per Capita Average Gastrointestinal Drugs Expenditure, 2015-2025, Africa Countries
19.6. Africa Gastrointestinal Drugs Market, Segmentation by Type, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7. Africa Gastrointestinal Drugs Market: Country Analysis
19.7.1. Egypt Gastrointestinal Drugs Market
19.7.1.1. Egypt Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.2. Nigeria Gastrointestinal Drugs Market
19.7.2.1. Nigeria Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)
19.7.3. South Africa Gastrointestinal Drugs Market
19.7.3.1. South Africa Gastrointestinal Drugs Market, 2015-2020, 2020-2025F, 2030F, Value ($ Billion)

20. Gastrointestinal Drugs Market Competitive Landscape
20.1. Competitive Market Overview
20.2. Market Shares
20.3. Company Profiles
20.3.1. Takeda Pharmaceticals
20.3.1.1. Company Overview
20.3.1.2. Products and Services
20.3.1.3. Strategy
20.3.1.4. Financial Performance
20.3.2. Allergan Plc
20.3.2.1. Company Overview
20.3.2.2. Products and Services
20.3.2.3. Strategy
20.3.2.4. Financial Performance
20.3.3. Novo Nordisk A/S
20.3.3.1. Company Overview
20.3.3.2. Products and Services
20.3.3.3. Strategy
20.3.3.4. Financial Performance
20.3.4. AstraZeneca Plc
20.3.4.1. Company Overview
20.3.4.2. Products and Services
20.3.4.3. Strategy
20.3.4.4. Financial Performance
20.3.5. Johnson & Johnson
20.3.5.1. Company Overview
20.3.5.2. Products and Services
20.3.5.3. Strategy
20.3.5.4. Financial Performance

21. Key Mergers and Acquisitions in the Gastrointestinal Drugs Market

22. Market Background: Pharmaceutical Drugs Market
22.1. Pharmaceutical Drugs Market Characteristics
22.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2020, 2020-2025F, 2030F Growth, by Segment, Value ($ Billion), Global
22.3. Global Pharmaceutical Drugs Market, 2020, by Region, Value ($ Billion)
22.4. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Historic and Forecast, by Region
22.5. Global Pharmaceutical Drugs Market, 2015-2020, 2020-2025F, 2030F, Segmentation by Type, Value ($ Billion)

23. Recommendations
23.1. Global Gastrointestinal Drugs Market in 2025 - Growth Countries
23.2. Global Gastrointestinal Drugs Market in 2025 - Growth Segments
23.3. Global Gastrointestinal Drugs Market in 2025 - Growth Strategies

24. Appendix
24.1. NAICS Definitions of Industry Covered in This Report
24.2. Abbreviations
24.3. Currencies
24.4. Research Inquiries
24.5. About the Publisher

25. Copyright and Disclaimer
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Allergan Plc
  • AstraZeneca Plc
  • Johnson & Johnson
  • Novo Nordisk A/S
  • Takeda Pharmaceticals
  • MORE
Major companies in the gastrointestinal drugs market include Takeda Pharmaceticals; Allergan Plc; Novo Nordisk A/S; AstraZeneca Plc and Johnson & Johnson.

The global gastrointestinal drugs market is expected to grow from $46.68 billion in 2020 to $48.74 billion in 2021 at a compound annual growth rate (CAGR) of 4.4%. The change in growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $62.19 billion in 2025 at a CAGR of 6%.

The gastrointestinal drugs market consists of sales of gastrointestinal drugs by entities (organizations, sole traders and partnerships) that produce gastrointestinal drugs to treat gastrointestinal diseases such as ulcerative colitis, diverticular disease, perianal infections, anal fissures, hemorrhoids, constipation, and irritable bowel syndrome. The key gastrointestinal diseases drug categories include Anti-peptic agents (antacids, antagonists, Proton Pump Inhibitors, Sucralfate, and Misoprostol), antiemetics, adsorbents, anticholinergics, opiates, intestinal flora modifiers, emollient/surfactants, hyperosmotic, saline, and simulant/irritant. The gastrointestinal drugs market is segmented into antacids; antiulcerants; vitamin and minerals; antiobesity; antiemetics and antinauseants; and antidiarrhoeals.

North America was the largest region in the global gastrointestinal drugs market, accounting for 48% of the market in 2020. Asia Pacific was the second largest region accounting for 24% of the global gastrointestinal drugs market. Africa was the smallest region in the global gastrointestinal drugs market.

Major companies in the gastrointestinal drug industry are investing in making oral capsules of macromolecular drugs for gastrointestinal diseases for making the drug more effective. Macromolecular drugs, such as peptides, proteins, and antibodies, form a new class of drugs which can treat diseases of the gastrointestinal tract, such as inflammatory bowel disease. These macromolecular drugs are usually injected and only a fraction of the administered dose reaches the disease sites in the gastrointestinal tract. Thus, major companies such as Eli Lilly have been increasingly investing in making oral capsules for macromolecular drugs. In December 2017, the company invested $5 million to enter into a collaboration with Entrega to study the oral delivery of complex molecules, such as peptides to combat gastrointestinal diseases.

During the historic period, the growth of the gastrointestinal drugs market was restrained by patent expiration of branded gastrointestinal drugs. In general, pharmaceutical companies invest a large sum of money in the drug development process and patents. During the patency period, the company holding the patent holds exclusivity for the manufacturing and distribution of drugs. Post expiration of patency, generic versions of the drugs are manufactured by other companies with prices much lower than the original branded drugs. Overall, this negatively impacts the growth of the market in terms of value.

The aging population profile of most countries contributed to the growth of the gastrointestinal drugs market. The increase in patient pool due to rising geriatric population globally, contributed significantly to the growth of the market during the historic period. According to the Population Reference Bureau, the share of population over the age of 65 in the global population increased from 8% in 2015 to 9% in 2019. The global population aged 65 years or over was 703 million in 2019. This rise in the geriatric population increased the demand for medical care and drove the healthcare expenditure. This has led to increased demand for pharmaceuticals products, significantly impacting market growth during this period.
Note: Product cover images may vary from those shown
4 of 5
  • Takeda Pharmaceticals
  • Allergan Plc
  • Novo Nordisk A/S
  • AstraZeneca Plc
  • Johnson & Johnson
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll